Richard J. Knight, MD

Professor of Surgery, Institute for Academic Medicine
Houston Methodist
Weill Cornell Medical College


Education & Training

, University of Texas Medical School at Houston
, Mount Sinai Medical Center
, Tulane University
Publications

Hyperinsulinemia after pancreas transplantation: a risk for excessive weight gani, metabolic syndrome, and fatty liver disease.
Knight, R 2016, 26th International Congress of the Transplantation Society, Hong Kong, China, 8/18/16 - 8/20/16, .

Combination Drug Products for HIV—A Word of Caution for the Transplant Clinician
Patel, SJ, Kuten, SA, Musick, WL, Gaber, AO, Monsour, HP & Knight, R 2016, American Journal of Transplantation, vol 16, no. 8, pp. 2479-2482. DOI:

Disparate rates of acute rejection and donor-specific antibodies among high-immunologic risk renal transplant subgroups receiving antithymocyte globulin induction
Patel, SJ, Suki, WN, Loucks-DeVos, J, Graviss, EA, Nguyen, DT, Knight, RJ, Kuten, SA, Moore, LW, Teeter, LD, Gaber, LW & Gaber, AO 2016, Transplant International, vol 29, no. 8, pp. 897-908.

Incidence and factors associated with de novo DSA after BK viremia in renal transplant recipients
Knight, R 2016, American Transplant Congress Boston 2016, Boston,MA, United States, 6/11/16 - 6/15/16, .

Long-term follow-up of renal transplant recipients treated with IVIG for de novo donor specific antibodies.
Knight, R 2016, American Transplant Congress Boston 2016, Boston,MA, United States, 6/11/16 - 6/15/16, .

Continuous antithymocyte globulin (rATG) for treatment of renal allograft rejection: Preliminary analysis of a prospective, randomized trial.
Knight, R 2016, American Transplant Congress Boston 2016, Boston,MA, United States, 6/11/16 - 6/15/16, .

Reduced-dose cidofovir and CMV-hyperimmune globulin for ganciclovir-resistant cytomegalovirus:Effective and kidney friendly.
Knight, R 2016, American Transplant Congress Boston 2016, Boston,MA, United States, 6/11/16 - 6/15/16, .

Disparate rates of acute rejection and donor-specific antibodies among high-immunologic risk renal transplant subgroups receiving antithymocyte globulin induction
Patel, SJ, Suki, WN, Loucks-DeVos, J, Graviss, EA, Nguyen, DT, Knight, RJ, Kuten, SA, Moore, LW, Teeter, LD, Gaber, LW & Gaber, AO 2016, Transplant International, vol 29, no. 8, pp. 897-908. DOI:

Disparate rates of acute rejection and donor-specific antibodies among high-immunologic risk renal transplant subgroups receiving antithymocyte globulin induction
Patel, SJ, Suki, WN, Loucks-Devos, J, Graviss, EA, Nguyen, DT, Knight, RJ, Kuten, SA, Moore, LW, Teeter, LD, Gaber, LW & Gaber, AO 2016, Transplant International.

Intermediate-Term Outcomes of Dual Adult versus Single-Kidney Transplantation: Evolution of a Surgical Technique
Islam, AK, Knight, RJ, Mayer, WA, Hollander, AB, Patel, S, Teeter, LD, Graviss, EA, Saharia, A, Podder, H, Asham, EH & Gaber, AO 2016, The Journal of Heart Transplantation, vol 2016, pp. 2586761. DOI:

Excessive Weight Gain After Pancreas Transplant: Transitioning from Type 1 to Type 2 Diabetes?
Islam, AK, Lawless, A, Teeter, LD, Graviss, E, Victor, III, DW, Sadhu, A, Patel, SJ, Gaber, AO & Knight, R 2015, American Journal of Transplantation, vol 2015, no. 15 (suppl3), 2015; 15.

Excessive Weight Gain After Pancreas Transplant: Transitioning from Type 1 to Type 2 Diabetes?
Victor, III, DW, Islam, A, Lawless, A, Teeter, L, Graviss, E, Sadhu, A, Patel, S, Gaber, AO & Knight, R 2015, .

Barriers to preemptive renal transplantation: a single center questionnaire study
Knight, RJ, Teeter, LD, Graviss, EA, Patel, SJ, DeVos, JM, Moore, LW & Gaber, AO 2015, Transplantation, vol 99, no. 3, pp. 576-579. DOI:

Observations on the use of cidofovir for BK virus infection in renal transplantation
Kuten, SA, Patel, SJ, Knight, RJ, Gaber, LW, Devos, JM & Gaber, AO 2015, Transplant Infectious Disease, vol 16, no. 6, pp. 975-983. DOI:

Intermediate-term graft loss after renal transplantation is associated with both donor-specific antibody and acute rejection
Devos, JM, Gaber, AO, Teeter, LD, Graviss, EA, Patel, SJ, Land, GA, Moore, LW & Knight, RJ 2014, Transplantation, vol 97, no. 5, pp. 534-540. DOI:

Resolution of Mild Ganciclovir-Resistant Cytomegalovirus Disease with Reduced-Dose Cidofovir and CMV-Hyperimmune Globulin
Patel, SJ, Kuten, SA, Knight, RJ, Hong, DM & Gaber, AO 2014, Journal of Heart Transplantation, vol 2014, pp. 342319. DOI:

A surgeons' guide to renal transplant immunopathology, immunology, and immunosuppression
Gaber, LW , Knight, RJ & Patel, SJ 2013, Surgical Clinics of North America, vol 93, no. 6, pp. 1293-1307. DOI:

Screening for BK viremia reduces but does not eliminate the risk of BK nephropathy
Knight, RJ , Gaber, LW, Patel, SJ, Devos, JM, Moore, LW & Gaber, AO 2013, Transplantation, vol 96, no. 7. DOI:

Cross-sectional and case-control analyses of the association of kidney function staging with adverse postoperative outcomes in general and vascular surgery
Gaber, AO , Moore, LW, Aloia, TA, Suki, WN, Jones, SL, Graviss, EA, Knight, RJ & Bass, BL 2013, Annals of Surgery, vol 258, no. 1, pp. 169-177. DOI:

Comparison of laparoendoscopic single site (LESS) and conventional laparoscopic donor nephrectomy at a single institution
Stamatakis, L, Mercado, MA, Choi, JM, Sanchez, EJ, Gaber, AO, Knight, RJ, Mayer, WA & Link, RE 2013, BJU International, vol 112, no. 2, pp. 198-206. DOI: